News

Santé log1h
Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building. NEW ...
Santé log4h
Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights
Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...
Santé log16h
Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD
SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...
Santé log16h
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), an AI-driven precision medicine company that leverages AI/ML platforms to improve outcomes for cancer and neurologically ...
Santé log1h
Epilepsy Foundation of America to Present Lifetime Accelerator Award to Orrin Devinsky, M.D.
Internationally acclaimed neurologist and epilepsy researcher Dr. Orrin Devinsky will be honored with the Lifetime Accelerator Award during the Epilepsy Therapies & Diagnostics Development Symposium ...
Santé log1h
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment ; The company will celebrate on social media, sharing patient and ...
Santé log1h
Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations
ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.
Santé log1h
Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories
Columbia University, the Company’s collaboration partner for pre-clinical development, granted Silo an exclusive global license to further develop, manufacture, and commercialize SPC-15 worldwide.
Santé log1h
Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt ...
Santé log1h
Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors
“I also want to thank Dale for his innumerable contributions to Outset during a critical period for the company. The experience, guidance and insights he brought to the board will have a lasting ...
Santé log1h
The Dwayne Andrews Glioblastoma Research Grant Awarded to Dr. Jeremy Brown, Dalhousie University
The Dwayne Andrews Glioblastoma Research Grant has been made possible through the generous support of the Auto|One Group and The Andrews Family.
Santé log1h
Autonomix CEO Brad Hauser to Present at Virtual Investor’s Closing Bell Event
THE WOODLANDS, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted ...